Clinical Scorecard: Comparison of β-Lactam and Non–β-Lactam Antibiotic Prophylaxis in Elective Colorectal Surgical Procedures
At a Glance
Category
Detail
Condition
Surgical site infections (SSIs) following elective colorectal surgery
Key Mechanisms
β-Lactam antibiotics provide reliable coverage of common surgical pathogens, favorable pharmacokinetics for dosing and redosing, and dosing simplicity; non–β-lactam alternatives are often used due to reported allergies but may have higher SSI rates
Target Population
Adult patients (≥18 years) undergoing elective colorectal surgery
Care Setting
Hospital surgical care, including community and academic hospitals
Key Highlights
β-Lactam antibiotics are preferred for surgical prophylaxis due to appropriate spectrum, potency, safety, and cost-effectiveness.
Non–β-lactam alternatives are frequently prescribed in patients with documented β-lactam allergies despite low cross-reactivity risk.
Higher SSI rates have been associated with non–β-lactam prophylaxis in colorectal surgery even after controlling for guideline-concordant dosing and timing.
Guideline-Based Recommendations
Diagnosis
Use standardized definitions for 30-day SSI and Clostridioides difficile infection (CDI) per MSQC standards.
Management
Administer β-lactam antibiotics (e.g., cefazolin plus metronidazole, cefoxitin, cefotetan, ampicillin-sulbactam, ceftriaxone plus metronidazole, ertapenem) as first-line surgical prophylaxis.
Use non–β-lactam alternatives (clindamycin plus aminoglycoside or fluoroquinolone plus metronidazole) only when β-lactams are contraindicated due to allergy.
Ensure guideline-concordant antibiotic dosing and timing per Surgical Care Improvement Project and American Society of Health-System Pharmacists guidelines.
Monitoring & Follow-up
Monitor for 30-day postoperative SSIs and CDI using validated registry data and standardized definitions.
Audit antibiotic dosing and timing adherence to guidelines to optimize prophylaxis effectiveness.
Risks
Non–β-lactam prophylaxis is associated with increased risk of SSIs compared to β-lactam regimens.
Potential misclassification of β-lactam allergy may lead to unnecessary use of less effective prophylaxis.
Patient & Prescribing Data
Patients undergoing elective colorectal surgery receiving surgical infection prophylaxis
Patients with documented β-lactam allergies often receive non–β-lactam alternatives, which may increase SSI risk; adherence to guideline-concordant dosing and timing is critical for prophylaxis efficacy.
Clinical Best Practices
Prefer β-lactam antibiotics for surgical prophylaxis in elective colorectal procedures unless contraindicated.
Confirm and clarify reported β-lactam allergies to avoid unnecessary use of non–β-lactam alternatives.
Adhere strictly to guideline-recommended antibiotic dosing and timing to maximize prophylactic effectiveness.
Exclude patients with urgent/emergent surgery, inappropriate wound classification, or non-guideline-concordant antibiotic use from prophylaxis protocols.
Use validated surgical quality collaborative data and standardized definitions for outcome assessment.
